HUP0202338A3 - Pharmaceutical composition containing fenofibrate and preparation method - Google Patents

Pharmaceutical composition containing fenofibrate and preparation method

Info

Publication number
HUP0202338A3
HUP0202338A3 HU0202338A HUP0202338A HUP0202338A3 HU P0202338 A3 HUP0202338 A3 HU P0202338A3 HU 0202338 A HU0202338 A HU 0202338A HU P0202338 A HUP0202338 A HU P0202338A HU P0202338 A3 HUP0202338 A3 HU P0202338A3
Authority
HU
Hungary
Prior art keywords
preparation
pharmaceutical composition
composition containing
containing fenofibrate
fenofibrate
Prior art date
Application number
HU0202338A
Other languages
English (en)
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0202338(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of HUP0202338A2 publication Critical patent/HUP0202338A2/hu
Publication of HUP0202338A3 publication Critical patent/HUP0202338A3/hu
Publication of HU229044B1 publication Critical patent/HU229044B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
HU0202338A 1999-07-09 2000-07-07 Fenofibrátot tartalmazó gyógyszerkészítmények és eljárás elõállításukra HU229044B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908923A FR2795961B1 (fr) 1999-07-09 1999-07-09 Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
PCT/FR2000/001971 WO2001003693A1 (fr) 1999-07-09 2000-07-07 Composition pharmaceutique contenant du fenofibrate et procede de preparation

Publications (3)

Publication Number Publication Date
HUP0202338A2 HUP0202338A2 (en) 2002-10-28
HUP0202338A3 true HUP0202338A3 (en) 2003-03-28
HU229044B1 HU229044B1 (hu) 2013-07-29

Family

ID=9547923

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202338A HU229044B1 (hu) 1999-07-09 2000-07-07 Fenofibrátot tartalmazó gyógyszerkészítmények és eljárás elõállításukra

Country Status (37)

Country Link
US (4) US7101574B1 (hu)
EP (3) EP1523983B1 (hu)
JP (2) JP4841092B2 (hu)
KR (3) KR20020025188A (hu)
CN (2) CN1204885C (hu)
AT (3) ATE399006T1 (hu)
AU (1) AU782282B2 (hu)
BG (1) BG65504B1 (hu)
BR (1) BR0012335A (hu)
CA (1) CA2377909C (hu)
CY (1) CY1106206T1 (hu)
CZ (1) CZ300094B6 (hu)
DE (3) DE60039313D1 (hu)
DK (3) DK1194140T3 (hu)
EA (1) EA004294B1 (hu)
EE (1) EE04995B1 (hu)
ES (3) ES2271924T3 (hu)
FR (1) FR2795961B1 (hu)
GE (1) GEP20043287B (hu)
HK (3) HK1044894B (hu)
HR (1) HRP20020111B1 (hu)
HU (1) HU229044B1 (hu)
IL (2) IL147499A0 (hu)
IS (1) IS2157B (hu)
ME (1) ME01361B (hu)
MX (1) MXPA02000324A (hu)
NO (1) NO333301B1 (hu)
NZ (1) NZ516416A (hu)
PL (1) PL212082B1 (hu)
PT (3) PT1194140E (hu)
RS (1) RS50035B (hu)
SI (2) SI1194140T1 (hu)
SK (1) SK287484B6 (hu)
TR (1) TR200200008T2 (hu)
UA (1) UA72925C2 (hu)
WO (1) WO2001003693A1 (hu)
ZA (1) ZA200200169B (hu)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795961B1 (fr) * 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
FR2819720B1 (fr) * 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
AU2003270778B2 (en) 2002-09-20 2009-10-08 Alpharma Pharmaceuticals, Llc Sequestering subunit and related compositions and methods
AU2003263480A1 (en) * 2002-09-24 2004-04-19 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CN100367947C (zh) * 2002-12-04 2008-02-13 徐州恩华赛德药业有限责任公司 具有抗高血脂症的含非诺贝特的药物组合物
US20080051411A1 (en) * 2002-12-17 2008-02-28 Cink Russell D Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
EP1829541A1 (en) * 2002-12-17 2007-09-05 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
EP1572190B1 (en) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
MXPA06000111A (es) * 2003-07-02 2006-04-27 Abbott Lab Proceso para preparar formulaciones de farmacos que regulan lipidos.
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8026281B2 (en) * 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
BRPI0606187A2 (pt) * 2005-02-25 2009-06-09 Hoffmann La Roche comprimidos com capacidade de dispersão da substáncia do fármaco melhorada
JP2008505934A (ja) * 2005-03-30 2008-02-28 テバ ファーマシューティカル インダストリーズ リミティド メンソール又はｐｅｇ／ポロキサマーを含むフェノフィブレートの改良された製剤
US20080152714A1 (en) * 2005-04-08 2008-06-26 Yi Gao Pharmaceutical Formulations
AU2007252308A1 (en) * 2006-05-23 2007-11-29 Intelemetrix Ltd Data accessing system and method
HUE032156T2 (hu) 2006-06-19 2017-09-28 Alpharma Pharmaceuticals Llc Gyógyszerészeti készítmények
KR100767349B1 (ko) * 2006-08-01 2007-10-17 삼천당제약주식회사 페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법
EP1923053A1 (en) * 2006-09-27 2008-05-21 Novartis AG Pharmaceutical compositions comprising nilotinib or its salt
EP2073797A2 (en) * 2006-10-11 2009-07-01 Alpharma, Inc. Pharmaceutical compositions
JP4993274B2 (ja) * 2006-12-05 2012-08-08 日医工株式会社 フェノフィブラート含有製剤組成物の製造方法
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
EP2224805A4 (en) * 2007-12-17 2013-10-16 Alpharma Pharmaceuticals Llc PHARMACEUTICAL COMPOSITION
FR2940118B1 (fr) * 2008-12-24 2013-08-09 Ethypharm Sa Formulation pharmaceutique de fenofibrate nanonise
JPWO2010092925A1 (ja) * 2009-02-12 2012-08-16 あすか製薬株式会社 固体分散体とその医薬組成物、並びにそれらの製造方法
CN101502497B (zh) * 2009-03-06 2010-11-10 安徽省药物研究所 非诺贝特药物组合物
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
KR101202994B1 (ko) * 2010-04-12 2012-11-21 한미사이언스 주식회사 페노피브린산 및 알칼리화제를 포함하는 경구용 약학 조성물
US20140255480A1 (en) * 2011-09-07 2014-09-11 Ethypharm Pharmaceutical formulation of nanonized fenofibrate
KR101334585B1 (ko) * 2012-05-29 2013-12-05 주식회사 브이터치 프로젝터를 통해 표시되는 정보를 이용하여 가상터치를 수행하는 원격 조작 장치 및 방법
US8722083B2 (en) 2012-06-25 2014-05-13 Mylan, Inc. Fenofibrate formulation
WO2014091318A1 (en) 2012-12-11 2014-06-19 Lupin Atlantis Holdings, S.A. Reduced dose pharmaceutical compositions of fenofibrate
US20160289393A1 (en) * 2013-12-04 2016-10-06 Dow Global Technologies Llc Process for prepring a mixture of a cellulose derivative and a liquid diluent
CN104352466A (zh) * 2014-11-17 2015-02-18 辰欣药业股份有限公司 一种非诺贝特组合物及其制剂
CN107961224B (zh) * 2017-12-06 2021-05-04 齐鲁制药(海南)有限公司 一种阿昔替尼片及其制备方法
KR102407512B1 (ko) 2019-10-30 2022-06-13 주식회사 대웅테라퓨틱스 피브레이트계 화합물을 포함하는 근육 질환 예방 및 치료용 조성물
CN112121022A (zh) * 2020-09-25 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物及其制备方法
WO2022071768A1 (en) * 2020-09-29 2022-04-07 Addpharma Inc. A pharmaceutical composition comprising fenofibrate particles with improved bioavailability
CN112121023A (zh) * 2020-09-30 2020-12-25 迪沙药业集团有限公司 一种非诺贝特片组合物

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058552A (en) 1969-01-31 1977-11-15 Orchimed Sa Esters of p-carbonylphenoxy-isobutyric acids
CH543472A (fr) 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
GB1579818A (en) 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4344934A (en) 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
EP0012523B2 (en) 1978-11-20 1988-02-03 American Home Products Corporation Therapeutic compositions with enhanced bioavailability and process for their preparation
FR2494112B1 (hu) * 1980-11-19 1986-01-10 Laruelle Claude
GB8414220D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
GB8414221D0 (en) 1984-06-04 1984-07-11 Sterwin Ag Unit dosage form
FR2602423B1 (fr) 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
US4752470A (en) 1986-11-24 1988-06-21 Mehta Atul M Controlled release indomethacin
US4895725A (en) * 1987-08-24 1990-01-23 Clinical Technologies Associates, Inc. Microencapsulation of fish oil
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
ES2056470T3 (es) 1990-07-02 1994-10-01 Boehringer Mannheim Gmbh Proceso para la obtencion de dosis unitarias de liberacion retardada, prensadas en molde, y las dosis unitarias correspondientes.
JP3125221B2 (ja) * 1990-09-01 2001-01-15 大正製薬株式会社 ソファルコン含有固形製剤
JP3037393B2 (ja) * 1990-10-22 2000-04-24 大正薬品工業株式会社 経口投与用固形薬剤の製造方法
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5223268A (en) * 1991-05-16 1993-06-29 Sterling Drug, Inc. Low solubility drug-coated bead compositions
ATE156707T1 (de) * 1991-06-21 1997-08-15 Ilsan Ilac Ve Hammaddeleri San Neues galenisches verfahren für omeprazol enthaltende pellets
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
EP0914100A1 (en) * 1996-06-28 1999-05-12 Schering Corporation Oral composition comprising a triazole antifungal compound
FR2758461A1 (fr) 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
AU2005299A (en) * 1997-12-20 1999-07-12 Genencor International, Inc. Fluidized bed matrix granule
JP2000086509A (ja) * 1998-09-14 2000-03-28 Taisho Yakuhin Kogyo Kk ソファルコン含有製剤の製造方法
FR2783421B1 (fr) * 1998-09-17 2000-11-24 Cll Pharma Procede de preparation de nouvelles formulations galeniques du fenofibrate, formulations galeniques obtenues par ledit procede et leurs applications
US6368620B2 (en) * 1999-06-11 2002-04-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7863331B2 (en) * 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
WO2002024169A1 (en) * 2000-09-20 2002-03-28 Skyepharma Canada Inc. Spray drying process and compositions of fenofibrate
US8026281B2 (en) 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate

Also Published As

Publication number Publication date
ATE399006T1 (de) 2008-07-15
ES2271924T3 (es) 2007-04-16
BG65504B1 (bg) 2008-10-31
NO333301B1 (no) 2013-04-29
BG106280A (en) 2002-08-30
DE60039313D1 (de) 2008-08-07
EE04995B1 (et) 2008-04-15
IS6218A (is) 2002-01-03
AU782282B2 (en) 2005-07-14
UA72925C2 (uk) 2005-05-16
DK1523983T3 (da) 2008-10-13
US20070071812A1 (en) 2007-03-29
TR200200008T2 (tr) 2002-06-21
IS2157B (is) 2006-11-15
CN1682707B (zh) 2010-05-05
DE60019120T2 (de) 2006-02-09
ATE291912T1 (de) 2005-04-15
KR20020025188A (ko) 2002-04-03
EP1523983B1 (fr) 2008-06-25
FR2795961A1 (fr) 2001-01-12
HUP0202338A2 (en) 2002-10-28
WO2001003693A1 (fr) 2001-01-18
CZ20022A3 (cs) 2002-05-15
FR2795961B1 (fr) 2004-05-28
MXPA02000324A (es) 2002-06-21
IL147499A0 (en) 2002-08-14
DE60031184D1 (de) 2006-11-16
HK1044894B (zh) 2005-06-24
NO20020014L (no) 2002-03-04
SI1194140T1 (en) 2005-06-30
ES2309438T3 (es) 2008-12-16
EP1574214A1 (fr) 2005-09-14
NO20020014D0 (no) 2002-01-02
PT1523983E (pt) 2008-09-19
DE60019120D1 (de) 2005-05-04
YU93201A (sh) 2004-09-03
ME01361B (me) 2008-11-28
ATE341320T1 (de) 2006-10-15
HK1074588A1 (en) 2005-11-18
US20110159082A1 (en) 2011-06-30
EP1194140A1 (fr) 2002-04-10
US8563042B2 (en) 2013-10-22
EA200200147A1 (ru) 2002-06-27
EE200200011A (et) 2003-02-17
PL212082B1 (pl) 2012-08-31
DE60031184T2 (de) 2007-08-23
JP2011148813A (ja) 2011-08-04
CA2377909A1 (fr) 2001-01-18
HRP20020111A2 (en) 2003-04-30
ES2235919T3 (es) 2005-07-16
KR20070026716A (ko) 2007-03-08
HK1080391A1 (en) 2006-04-28
CN1204885C (zh) 2005-06-08
EP1574214B1 (fr) 2006-10-04
NZ516416A (en) 2003-10-31
PT1194140E (pt) 2005-07-29
CZ300094B6 (cs) 2009-01-28
KR20060073549A (ko) 2006-06-28
KR100766644B1 (ko) 2007-10-15
EP1523983A1 (fr) 2005-04-20
GEP20043287B (en) 2004-07-26
US20080248101A1 (en) 2008-10-09
CA2377909C (fr) 2011-06-28
HRP20020111B1 (en) 2005-12-31
PL352307A1 (en) 2003-08-11
DK1574214T3 (da) 2007-01-22
US7101574B1 (en) 2006-09-05
RS50035B (sr) 2008-11-28
SK152002A3 (en) 2002-07-02
DK1194140T3 (da) 2005-07-04
CY1106206T1 (el) 2011-06-08
CN1360499A (zh) 2002-07-24
SI1574214T1 (sl) 2006-12-31
EA004294B1 (ru) 2004-02-26
JP2003504331A (ja) 2003-02-04
US8658212B2 (en) 2014-02-25
ZA200200169B (en) 2002-07-31
HU229044B1 (hu) 2013-07-29
BR0012335A (pt) 2002-03-19
IL147499A (en) 2007-03-08
HK1044894A1 (en) 2002-11-08
SK287484B6 (sk) 2010-11-08
AU6296000A (en) 2001-01-30
PT1574214E (pt) 2007-01-31
CN1682707A (zh) 2005-10-19
JP4841092B2 (ja) 2011-12-21
EP1194140B1 (fr) 2005-03-30

Similar Documents

Publication Publication Date Title
HUP0202338A3 (en) Pharmaceutical composition containing fenofibrate and preparation method
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
HUP0200831A2 (en) Novel pharmaceutical composition containing amoxycillin and its use
ZA200110022B (en) Thiazoloderivatives and pharmaceutical compositions containing them.
HUP0203028A3 (en) Pharmaceutical formulation containing tolterodine and its use
HUP0204081A3 (en) 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
IL136251A0 (en) Soft pellet drug composition and methods for the preparation thereof
HUP0203505A3 (en) 2'-substituted 1,1'-biphenyl-2-carbonamides, and pharmaceutical compositions containing said compounds
HUP0200275A3 (en) Seed treatment composition and preparation thereof
HUP0203194A3 (en) Phenylpiperazines, pharmaceutical compositions containing them and their use
HUP0203735A3 (en) 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use
HUP0105481A3 (en) Pharmaceutical compositions containing clarithromycin and process for their preparation and their use
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
AP2001002371A0 (en) Streptogramin derivatives preparation and compositions containing them
HUP0200055A3 (en) 16-hydroxyestrienes and pharmaceutical compositions containing the same
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
HUP0104834A3 (en) Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
HUP0003074A3 (en) Pharmaceutical composition comprising ssri and betha-blocking agent
HUP9701293A3 (en) New salts without unsavoury taste and pharmaceutical compositions containing them
HUP0104544A2 (en) New pharmaceutical composition and the process for its preparation

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees